Annual report pursuant to Section 13 and 15(d)

Equity-classified Warrants - Schedule of outstanding warrants (Details)

v3.22.0.1
Equity-classified Warrants - Schedule of outstanding warrants (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Number of Shares  
Outstanding at December 31, 2019 | shares 240,100
Granted | shares 240,100
Outstanding at December 31, 2020 | shares 240,100
Weighted Average Exercise Price  
Outstanding at December 31, 2019 | $ / shares $ 11.00
Granted | $ / shares 11.00
Outstanding at December 31, 2020 | $ / shares $ 11.00
Remaining Contractual Term (years)  
Outstanding at December 31, 2019 4 years 7 months 2 days
Granted 5 years
Outstanding at December 31, 2020 4 years 7 months 2 days
Average Intrinsic Value  
Ending balance | $ $ 6,012,104